Rheumatological autoimmune, inflammatory and metabolic bone disorders [NG167], NICE (updated 31st March 2021)

The purpose of this guideline is to maximise the safety of children and adults with rheumatological autoimmune, inflammatory and metabolic bone disorders during the COVID-19 pandemic, while protecting staff from infection. It also enables services to make the best use of NHS resources. On 31 March 2021, we integrated content from the NHS England specialty guide on rheumatology during the coronavirus pandemic into this guideline. This includes information on making treatment decisions based on the person ' s condition and their medicines, advice on shielding and self-isolation, and recommendations on organising services based on COVID-19 prevalence.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news